The Canada legal cannabis market size is expected to reach USD 5.79 billion by 2030, registering a CAGR of 10.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high demand for CBD for health and wellness purposes, attributed to its therapeutic properties, is a key driver in the market’s growth.
Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, in February 2024, researchers at the University of British Columbia introduced a first-of-its-kind clinical trial examining the potential of CBD as a treatment for bipolar depression. The trials were approved by Health Canada and funded by the Canadian Institutes of Health Research (CIHR) to investigate how CBD can help manage acute bipolar depression.
Canada Legal Cannabis Market Report Highlights
- Based on source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana-based products
- Based on derivatives, the CBD segment held the largest market share in 2023, owing to the awareness regarding CBD’s effectiveness in treating various medical conditions
- Based on cultivation, the indoor segment held the largest market share in 2023 due to the incorporation of artificial intelligence (AI) in cannabis cultivation, rising investments, and favorable government initiatives
- Based on end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing consumption of cannabis in the form of vapes, foods, and beverages
For More Details or Sample Copy please visit link @: Canada Legal Cannabis Market Report
Moreover, medical professionals’ increasing preference for cannabinoid-based formulations to treat numerous health conditions is another major factor supporting the country’s market. Healthcare professionals’ higher preference for CBG, CBN-derived products creates a positive influence on consumer minds, thereby boosting their adoption rate and popularity. For instance, in October 2021, Cronos Group Inc. launched its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy that features THC and cultured CBG.
Some of the key players in the market are Canopy Growth Corporation, Charlotte’s Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Maricann, Inc. These market players adopt key strategic initiatives to expand their business footprint and market position. For instance, in April 2023, Aurora Cannabis Inc. partnered with Strainprint and announced the launch of the tracking program through Strainprint App. The tracking program is designed for Aurora patients to keep track of their medical cannabis journey.
Furthermore, the rise in awareness regarding cannabis and its potential use in various industries and the introduction of educational programs boost the market growth. For instance, in July 2022, Tilray Brands launched a cannabis education platform, WeCare-Medical Cannabis. The platform is dedicated to educating patients and healthcare practitioners about medical cannabis.
List of major companies in the Canada Legal Cannabis Market
- Canopy Growth Corporation
- Charlotte’s Web, Inc.
- Aurora Cannabis Inc.
- Tilray Brands
- The Cronos Group
- Jazz Pharmaceuticals, Inc.
- Sundial Growers
- Organigram Holding, Inc.
- Maricann, Inc.
For Customized reports or Special Pricing please visit @: Canada Legal Cannabis Market Analysis Report
We have segmented the Canada legal cannabis market on the basis of source, derivatives, cultivation, end-use, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#LegalCannabisCanada #CannabisMarket #CannabisIndustry #CanadaCannabis #CannabisLegalization #CannabisRetail #CannabisResearch #MedicalCannabis #RecreationalCannabis #CannabisTrends #CannabisRegulations #CannabisCultivation #CannabisDistribution #CBDCanada #THCProducts #CannabisPolicy #CannabisEconomy #CannabisStocks
